BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23678991)

  • 1. X4 viruses are frequently archived in patients with long-term HIV infection but do not seem to influence the "inflamm-aging" process.
    Saracino A; Monno L; Scudeller L; Bruno G; Ladisa N; Punzi G; Volpe A; Lagioia A; Angarano G
    BMC Infect Dis; 2013 May; 13():220. PubMed ID: 23678991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-receptor switch during HAART is independent of virological success.
    Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
    J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next generation sequencing reveals a high frequency of CXCR4 utilizing viruses in HIV-1 chronically infected drug experienced individuals in South Africa.
    Matume ND; Tebit DM; Gray LR; Hammarskjold ML; Rekosh D; Bessong PO
    J Clin Virol; 2018 Jun; 103():81-87. PubMed ID: 29661652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of R5 and X4 HIV variants in antiretroviral treatment experienced patients with virologic failure.
    Ferrer P; Tello M; Montecinos L; Tordecilla R; Rodríguez C; Beltrán C; Guzmán MA; Ferrés M; Pérez CM; Afani A
    J Clin Virol; 2014 Jul; 60(3):290-4. PubMed ID: 24793966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1.
    Bader J; Däumer M; Schöni-Affolter F; Böni J; Gorgievski-Hrisoho M; Martinetti G; Thielen A; Klimkait T;
    Clin Infect Dis; 2017 Feb; 64(3):295-300. PubMed ID: 27838645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.
    Baroncelli S; Galluzzo CM; Weimer LE; Pirillo MF; Volpe A; Mercuri A; Cavalli A; Fragola V; Monno L; Degli Antoni A; Ladisa N; Francisci D; Bucciardini R; Floridia M
    J Antimicrob Chemother; 2012 Jun; 67(6):1479-85. PubMed ID: 22361986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher prevalence of predicted X4-tropic strains in perinatally infected older children with HIV-1 subtype C in India.
    Neogi U; Sahoo PN; Arumugam K; Sonnerborg A; De Costa A; Shet A
    J Acquir Immune Defic Syndr; 2012 Apr; 59(4):347-53. PubMed ID: 22107818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc.
    Cascajero A; Rastrojo A; Díez-Fuertes F; Hernández-Novoa B; Aguado B; Moreno S; Alcami J; Pérez-Olmeda M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.
    Soulié C; Fourati S; Lambert-Niclot S; Malet I; Wirden M; Tubiana R; Valantin MA; Katlama C; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2010 Apr; 65(4):749-51. PubMed ID: 20150182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
    Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.
    Arif MS; Hunter J; Léda AR; Zukurov JPL; Samer S; Camargo M; Galinskas J; Kallás EG; Komninakis SV; Janini LM; Sucupira MC; Diaz RS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28659473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects.
    Parisi SG; Andreoni C; Sarmati L; Boldrin C; Buonomini AR; Andreis S; Scaggiante R; Cruciani M; Bosco O; Manfrin V; d'Ettorre G; Mengoli C; Vullo V; Palù G; Andreoni M
    J Clin Microbiol; 2011 Apr; 49(4):1441-5. PubMed ID: 21367995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients.
    Saracino A; Cozzi-Lepri A; Shanyinde M; Ceccherini Silberstein F; Nozza S; Di Biagio A; Cassola G; Bruno G; Capobianchi M; Puoti M; Monno L; d'Arminio Monforte A;
    PLoS One; 2018; 13(1):e0190302. PubMed ID: 29324755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions.
    Zhou S; Bednar MM; Sturdevant CB; Hauser BM; Swanstrom R
    J Virol; 2016 Aug; 90(16):7142-58. PubMed ID: 27226378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does HIV-1 co-receptor tropism correlate with fibrosis progression in HIV/HCV co-infected patients?
    Saracino A; Bruno G; Scudeller L; Punzi G; Lagioia A; Ladisa N; Monno L; Angarano G
    J Clin Virol; 2014 Mar; 59(3):167-71. PubMed ID: 24461764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.
    Surdo M; Balestra E; Saccomandi P; Di Santo F; Montano M; Di Carlo D; Sarmati L; Aquaro S; Andreoni M; Svicher V; Perno CF; Ceccherini-Silberstein F
    PLoS One; 2013; 8(7):e68076. PubMed ID: 23874501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monophylogenetic HIV-1C epidemic in Ethiopia is dominated by CCR5-tropic viruses-an analysis of a prospective country-wide cohort.
    Kalu AW; Telele NF; Gebreselasie S; Fekade D; Abdurahman S; Marrone G; Sönnerborg A
    BMC Infect Dis; 2017 Jan; 17(1):37. PubMed ID: 28061826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X4 Tropic Virus Prediction Is Associated with a Nadir CD4 T-Cell Count below 100 Cells/mm.
    Sechet M; Roussel C; Schmit JL; Saroufim C; Ghomari K; Merrien D; Cordier F; Pik JJ; Landgraf N; Douadi Y; Liné D; Duverlie G; Castelain S
    Intervirology; 2015; 58(3):155-9. PubMed ID: 25997386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.